Company Filing History:
2 out of 87 
2 out of 2,619 
Years Active: 2022-2025
Title: **Innovative Contributions of Inventor Su Jin Seo from Daejeon, KR**
Introduction
Su Jin Seo, an accomplished inventor based in Daejeon, South Korea, holds a noteworthy patent for anti-angiopoietin-2 antibodies that contribute significantly to medical science. His innovations focus on addressing critical issues related to abnormal blood vessel formation, showcasing the potential to improve therapeutic outcomes for various diseases.
Latest Patents
The patent granted to Su Jin Seo is titled "Anti-angiopoietin-2 antibodies that induce Tie2 activation." This pioneering invention relates to mouse antibodies that specifically bind to angiopoietin-2 (Ang2), along with humanized anti-Ang2 antibodies derived from them. Notably, these antibodies possess a dual capability: they not only neutralize Ang2 but also activate the Tie2 receptor. The significant implication of this patent is the potential to normalize abnormal and pathological blood vessels, providing therapeutic efficacy against conditions associated with such abnormalities. Additionally, the patent details compositions for treating diseases linked to abnormal Ang2 expression and Tie2 dysregulation, as well as diagnostic compositions for assessing Ang2 inhibition and Tie2 activation.
Career Highlights
Throughout his career, Su Jin Seo has made substantial contributions in the field of biomedical research. He has been associated with the Institute for Basic Science and the Korea Advanced Institute of Science and Technology. His work, particularly in antibody development, has positioned him as a key figure in advancing therapeutic strategies for vascular-related diseases.
Collaborations
In his professional journey, Su Jin Seo has collaborated with esteemed coworkers, including Gou Young Koh and Jeomil Bae. These collaborations have facilitated knowledge exchange and innovation, further enhancing the impact of their collective research efforts.
Conclusion
Su Jin Seo's innovative work on anti-angiopoietin-2 antibodies exemplifies the transformative potential of targeted therapies in healthcare. With his patent underlining significant advancements in treating diseases associated with abnormal blood vessels, Seo represents a driving force in research that may lead to improved clinical outcomes. His contributions to the fields of medicine and science continue to inspire future innovation and exploration.